1-4 of 4
Ruben Abagyan, PhD
Close
Sort by
Journal Articles

Small Molecule Inhibitor of Neutrophil Elastase Normalizes Myeloid Differentiation and Improves Impaired Cell Survival Triggered by Elastase Mutations In Patients with Severe Congenital Neutropenia and Acute Myeloid Leukemia

Andrew A. Aprikyan, PhD, Vahagn Makaryan, MD, Maxim Totrov, PhD, Ruben Abagyan, PhD, David C. Dale, MD
Journal: Blood
Blood (2010) 116 (21): 386.
https://doi.org/10.1182/blood.V116.21.386.386
Published: 2010
Journal Articles

Small Molecule Inhibitor of Neutrophil Elastase and Severe Congenital Neutropenia.

Andrew A Aprikyan, PhD, Vahagn Makaryan, MD, Maxim Totrov, PhD, Ruben Abagyan, PhD, David C. Dale, MD
Journal: Blood
Blood (2009) 114 (22): 552.
https://doi.org/10.1182/blood.V114.22.552.552
Published: 2009
Journal Articles

Small Molecule Inhibitor of Neutrophil Elastase Restores Impaired Production of Human Myeloid Cells Observed in Severe Congenital Neutropenia.

Andrew A. Aprikyan, PhD, Vahagn Makaryan, MD, Qian Si, PhD, Kelly Treonze, PhD, Nara Markosyan, BS, Paul Finke, PhD, Maxim Totrov, PhD, Ruben Abagyan, PhD, Richard Mumford, BA, David Dale, MD
Journal: Blood
Blood (2007) 110 (11): 664.
https://doi.org/10.1182/blood.V110.11.664.664
Published: 2007
Journal Articles

Diversity and Molecular Modeling of Neutrophil Elastase Mutations in Patients with Severe Congenital Neutropenia and Acute Myelogenous Leukemia.

Andrew A.G. Aprikyan, PhD, Steve Stein, MD, Nara A. Markosyan, Maxim Totrov, PhD, Ruben Abagyan, PhD, David C. Dale, MD
Journal: Blood
Blood (2004) 104 (11): 1454.
https://doi.org/10.1182/blood.V104.11.1454.1454
Published: 2004